Results 231 to 240 of about 423,270 (353)

Adherence to Pharmacological Treatment in Chronic Venous Disease: Results of a Real-World, Prospective, Observational Cohort Study. [PDF]

Life (Basel)
Branisteanu DE, Munteanu AE, Dolofan BM, Popescu EG, Vittos O.   +4 more
europepmc   +1 more source

Prevalence and risk factors of chronic venous disease in medical students [PDF]

Marco Antonio Ayala‐García, Lisandra Soto Saldaña, Gilberto Flores-Vargas, Polo René Barrios Bañuelas, Coral Nathaly Cahuana Bravo, Miguel Ángel Vázquez Guerrero   +5 more
openalex   +1 more source

Human Atlas of Tooth Decay Progression: Identification of Cellular Mechanisms Driving the Switch from Dental Pulp Repair Toward Irreversible Pulpitis

Advanced Science, EarlyView.
Tooth decay progression transforms the dental pulp response from repair to fibrosis. At early stages, stromal cells reprogram to repair the extra cellular matrix (ECM), blood vessels, and nerves, remodel and grow, keeping repair possible. In advanced decay, hypoxia, and vessel regression, in complement with an immune switch, fuel nerve degeneration and
Hoang Thai Ha, Sofya Kosmynina, Amandine Verocq, Keremsah Ozen, Ines Tekia, Hugo Bussy, Marie Ramirez, Dima Sabbah, Chloe Goemans, Valerie Vandenbempt, Esteban N. Gurzov, Sumeet Pal Singh, Nicolas Baeyens   +12 more
wiley   +1 more source

Glycocalyx disruption, endothelial dysfunction and vascular remodeling as underlying mechanisms and treatment targets of chronic venous disease. [PDF]

Int Angiol
Diaz JA, Gianesini S, Khalil RA.
europepmc   +1 more source

Engineering Dimensional Configuration of Single‐Atom S‐Cu‐S Sites as Reversible Electron Station for Enhanced Peroxidase‐Mimicking

Advanced Science, EarlyView.
L‐cysteine triggers auto‐assembly of POD‐like 3D biomimetic S‐Cu‐S single‐atom nanozymes on MoS2 (MoCC). MoCC shows 16.3‐fold higher catalytic velocity and 17.9‐fold greater affinity than HRP, enabling efficient •OH generation via enhanced electron inversion and transfer.
Wenjie Ma, Qian He, Jiancheng Sun, Yiqing Chen, Hongfei Su, Ludan Zhang, Xiao He, Yuguang Wang, Changjian Xie, Zhiyong Zhang, Xin Zhou, Yuliang Zhao, Wenyan Yin   +12 more
wiley   +1 more source

A systematic review of anatomical reflux patterns in primary chronic venous disease. [PDF]

J Vasc Surg Venous Lymphat Disord
Tan MKH, Bootun R, Wang R, Onida S, Lane T, Davies AH.   +5 more
europepmc   +1 more source

A genetic risk score comprising known venous thromboembolism loci is associated with chronic venous disease in a multi-ethnic cohort

, 2015
Christina L. Wassel, Laura J. Rasmussen‐Torvik, Peter Callas, Julie O. Denenberg, Jon Peter Durda, Alexander P. Reiner, Nicholas L. Smith, Matthew Allison, Frits R. Rosendaal, Michael H. Criqui, Mary Cushman   +10 more
openalex   +2 more sources

CEREBRAL VENOUS THROMBOSIS DURING PREGNANCY IN PARTURIENT WITH CHRONIC INFLAMMATORY BOWEL DISEASE: CASE REPORT AND REVIEW OF THE LITERATURE

, 2020
Safia El Ayoubia, Nezha Oudghiri A., Anas Tazi Saouda   +2 more
openalex   +1 more source

Lactylation‐Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22‐Mediated Dephosphorylation of NLRP3

Advanced Science, EarlyView.
In MASLD, YTHDC1 undergoes increased lactylation and ubiquitination, reducing its expression. AARS1 mediates lactylation at lysine 565, while disrupted binding to LDHA further promotes lactylation, suppressing YTHDC1. This downregulation enhances PTPN22 mRNA stability, leading to NLRP3 dephosphorylation and activation, which exacerbates inflammation ...
Feng Zhang, Linghua Zeng, Kunkun Zou, Keying Lin, Fangting Yao, Jinglun Song, Shumeng Zhang, Hanshu Feng, Zhichao Yang, Chunlei Wang, Hongtao Diao, Xue Kong, Tengfei Pan, Joonki Kim, Tianqi Duo, Linqiang Li, Yu Bian   +16 more
wiley   +1 more source

High-intensity-focused ultrasound treatment for the chronic venous disease based on the Cure Conservatrice et Hémodynamique de l'Insuffisance Veineuse en Ambulatoire (CHIVA) strategy. [PDF]

J Vasc Surg Venous Lymphat Disord
Izquierdo Lamoca LM, Reyero Postigo T, Morán Escalona S, Giráldez Arranz JF, Aguinaco Acosta A.   +4 more
europepmc   +1 more source